IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.292
EU - Europa 4.852
AS - Asia 1.633
Continente sconosciuto - Info sul continente non disponibili 28
SA - Sud America 25
AF - Africa 15
OC - Oceania 9
Totale 13.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.940
GB - Regno Unito 1.373
IT - Italia 1.075
SG - Singapore 821
UA - Ucraina 556
DE - Germania 492
RU - Federazione Russa 349
CA - Canada 345
CN - Cina 325
DK - Danimarca 269
VN - Vietnam 264
SE - Svezia 224
IE - Irlanda 172
HK - Hong Kong 141
FI - Finlandia 112
FR - Francia 66
NL - Olanda 41
PL - Polonia 38
EU - Europa 27
PK - Pakistan 23
BE - Belgio 14
RO - Romania 14
BR - Brasile 12
IN - India 11
AT - Austria 9
LT - Lituania 9
ES - Italia 8
BD - Bangladesh 7
CH - Svizzera 7
AU - Australia 6
MA - Marocco 6
JP - Giappone 5
MG - Madagascar 5
MT - Malta 5
MX - Messico 5
CZ - Repubblica Ceca 4
IR - Iran 4
PH - Filippine 4
TH - Thailandia 4
AM - Armenia 3
CL - Cile 3
ID - Indonesia 3
IL - Israele 3
NZ - Nuova Zelanda 3
PE - Perù 3
TW - Taiwan 3
CO - Colombia 2
EC - Ecuador 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EE - Estonia 1
HU - Ungheria 1
KR - Corea 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 13.854
Salva come PNG Salva come JPEG
Città #
Southend 907
Chandler 733
Singapore 674
Fairfield 584
Houston 490
Woodbridge 468
San Mateo 436
Ann Arbor 422
Falls Church 406
Cambridge 331
Seattle 327
Jacksonville 320
Wilmington 285
Ashburn 252
Ottawa 251
Dearborn 214
Boardman 190
Dublin 170
Stevenage 164
Portsmouth 163
Beijing 152
Dong Ket 147
Pisa 140
Lawrence 132
Rome 81
Milan 75
Montréal 72
San Diego 61
Santa Clara 58
Fremont 53
Helsinki 51
London 50
Munich 46
Redwood City 39
Brooklyn 37
Warsaw 36
Hong Kong 35
Los Angeles 34
Dongguan 29
Florence 28
Old Bridge 27
Central District 26
Norwalk 23
Livorno 19
Washington 18
Genoa 16
Lappeenranta 15
Shenzhen 15
Assago 14
Brussels 14
Dallas 14
Shanghai 14
Frankfurt am Main 13
Serra 13
Amsterdam 12
Bologna 12
Guangzhou 11
Lucca 11
Nuremberg 11
Toronto 11
Islamabad 9
Kilburn 9
Nanjing 9
Redmond 9
Turin 9
Hanover 8
Mykolayiv 8
Naples 8
Palermo 8
Bari 7
Buti 7
Chengdu 7
Iowa City 7
Laurel 7
Perugia 7
Wandsworth 7
Bucharest 6
Cascina 6
Foggia 6
Padova 6
Pescia 6
Venice 6
Viareggio 6
Augusta 5
Casalecchio di Reno 5
Islington 5
Lahore 5
Lyngby 5
Mariano Comense 5
Medolago 5
Melita 5
Paris 5
Sciacca 5
Sector 3 5
Vienna 5
Wuhan 5
Osio Sopra 4
San Antonio 4
Simi Valley 4
Stavropol 4
Totale 9.701
Salva come PNG Salva come JPEG
Nome #
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 240
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 184
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 179
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 174
Treating chemoreflex in heart failure: modulation or demolition? 168
B-type natriuretic peptide secretion following scuba diving 163
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 157
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 157
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 153
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 153
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 153
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 151
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 150
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 145
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 143
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 138
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 137
Prediction of the chemoreflex gain by common clinical variables in heart failure 136
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 136
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 135
Prognostic value of plasma Renin activity in heart failure. 135
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 134
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 134
Breathless heart: only when the neck is deep in water? 133
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 132
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. 131
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 131
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 129
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 129
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 129
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 125
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 124
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 123
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure 123
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. 122
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 122
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 121
Plasma renin activity is an independent prognosticator in heart failure patients with kidney disease 114
A simple echocardiographic score to rule out cardiac amyloidosis 112
Adrenergic activation in heart failure: blockade or rebalance? 108
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 108
The paradox of low BNP levels in obesity 105
Diabetes is a predictor of effort tolerance and ventilatory efficiency in patients with moderate systolic dysfunction on beta-blocker therapy 105
How to take arms against central apneas in heart failure 105
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 105
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 104
High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice 104
Funzione endocrina cardiaca nello scompenso determinanti clinici, neuroormonali ed emodinamici 102
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 100
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 100
An atypical case of cardiac amyloidosis. 97
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 97
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 97
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 95
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 95
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 94
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 94
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 92
Recent knowledges on chemosensitivity to hypoxia and hypercapnia in cardiovascular disease. 92
Natruiretic peptides in heart failure. 91
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 91
Cheyne-Stokes respiration and heart failure: pathophysiologicaland clinical implications 90
OVEREXPRESSION OF ANG-(1-7) IMPROVES CARDIAC FUNCTION AND ATTENUATES LEFT VENTRICULAR REMODELING 90
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 88
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 88
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 88
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 86
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) 85
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 84
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 83
Management of complications of cardiac amyloidosis: 10 questions and answers 82
Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial 81
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 81
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 80
Improved survival in limited scleroderma-related pulmonary artery hypertension 79
The Breathless Heart - Apneas in Heart Failure 77
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 77
Validity of transit time–based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers 76
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 76
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 76
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 76
Troponin in non-ischaemic dilated cardiomyopathy 75
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 75
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 75
Use of hypocapnia for improved risk stratification in pulmonary arterial hypertension: should we return to respiratory pathophysiology? 75
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 74
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 73
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 72
Arterial hypertension and the turbulent ageing of the aortic valve 72
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 72
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 72
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 71
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 70
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 70
Renin profiling predicts neurohormonal response to sacubitril/valsartan 70
Reply 70
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 69
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 69
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 68
The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study 66
Totale 10.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020716 0 0 0 0 0 0 197 69 165 45 50 190
2020/20213.396 277 365 154 306 167 542 330 217 177 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/20252.011 65 80 466 207 596 585 12 0 0 0 0 0
Totale 14.093